Pathology, Diffusion MRI, Fractional anisotropy, Neuroscience and Nuclear medicine are his primary areas of study. His study in Dementia and Fabry disease is carried out as part of his studies in Pathology. His Dementia research incorporates themes from Alzheimer's disease, Positron emission tomography and Central nervous system disease.
Fractional anisotropy is a primary field of his research addressed under White matter. In his work, Protocol and Segmentation is strongly intertwined with Magnetic resonance imaging, which is a subfield of Neuroscience. His Nuclear medicine research focuses on subjects like Neuroimaging, which are linked to Reproducibility.
Andreas Fellgiebel focuses on Neuroscience, Dementia, Diffusion MRI, Internal medicine and Pathology. The Neuroscience study combines topics in areas such as Disease and Atrophy. His Dementia research includes themes of Alzheimer's disease, Positron emission tomography and Cognition.
He has researched Diffusion MRI in several fields, including Voxel, Nuclear medicine and Cognitive impairment. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Cardiology. His study looks at the relationship between Pathology and fields such as Magnetic resonance imaging, as well as how they intersect with chemical problems.
Andreas Fellgiebel mainly focuses on Dementia, Cognition, Cognitive decline, Internal medicine and Disease. Andreas Fellgiebel does research in Dementia, focusing on Caregiver burden specifically. His Cognition research is multidisciplinary, incorporating elements of White matter and Audiology.
His biological study spans a wide range of topics, including Psychological resilience and Neuropsychology. Andreas Fellgiebel works mostly in the field of Cognitive decline, limiting it down to concerns involving Gerontology and, occasionally, Amyloid β, Clinical Dementia Rating and Neuroimaging. His work on Apathy, Risk stratification and Cohort study as part of general Internal medicine study is frequently linked to Bupropion, therefore connecting diverse disciplines of science.
His main research concerns Cognition, ADAM10, Acitretin, Dementia diagnosis and Gynecology. His studies deal with areas such as Clinical endpoint and Activities of daily living as well as Cognition. His ADAM10 study spans across into fields like Alzheimer's disease, Immune system, Central nervous system, Blood–brain barrier and Neurogenesis.
Combining a variety of fields, including Acitretin, Retinoid, Pharmacology, Cleavage, Chemistry and Neurite, are what the author presents in his essays. His research on Dementia diagnosis often connects related areas such as Early detection.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
Andreas Fellgiebel;Paulo Wille;Matthias J Müller;Georg Winterer.
Dementia and Geriatric Cognitive Disorders (2004)
Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment.
Andreas Fellgiebel;Matthias J. Müller;Paulo Wille;Paulo R. Dellani.
Neurobiology of Aging (2005)
Functional implications of hippocampal volume and diffusivity in mild cognitive impairment
Matthias J. Müller;Dirk Greverus;Paulo Roberto Dellani;Carsten Weibrich.
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection
Stefan Teipel;Stefan Teipel;Alexander Drzezga;Michel J Grothe;Michel J Grothe;Henryk Barthel.
Lancet Neurology (2015)
CNS manifestations of Fabry's disease
Andreas Fellgiebel;Matthias J Müller;Lionel Ginsberg.
Lancet Neurology (2006)
Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI
Matthias J. Müller;Dirk Greverus;Carsten Weibrich;Paulo Roberto Dellani.
Neurobiology of Aging (2007)
The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity
Giovanni B. Frisoni;Clifford R. Jack;Martina Bocchetta;Corinna Bauer.
Alzheimers & Dementia (2015)
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging.
Igor Yakushev;Alexander Hammers;Andreas Fellgiebel;Irene Schmidtmann.
Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus
Andreas Fellgiebel;Paulo R. Dellani;Dirk Greverus;Armin Scheurich.
Psychiatry Research-neuroimaging (2006)
Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study.
Ingo Kilimann;Michel Grothe;Helmut Heinsen;Eduardo Joaquim Lopez Alho.
Journal of Alzheimer's Disease (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: